Phase 2 PTSD Trial, Recruiting NCT05989841 Sponsor: University of Nevada, Las Vegas Condition: PTSD
Back to Ptsd

Phase 2 PTSD Trial, Recruiting

NCT05989841
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a woman who has survived a sexual assault and came to an emergency care location within 72 hours of the assault
  • You are 18 years of age or older
  • You speak and understand English
  • You are able to agree to take part in the study on your own (give informed consent)
  • You own a smartphone with a continuous phone/data plan that you have had for more than 1 year
  • You use cannabis (marijuana) more than once a week, based on a substance use screening questionnaire
  • You score above 17 on a questionnaire measuring sensitivity to anxiety (confirm with trial site)

Who may not be able to join:

  • You are unable to give informed consent — for example, due to a serious injury affecting your ability to hear, speak, or see, or due to a diagnosed cognitive condition or dementia
  • You are currently in prison or jail
  • You are currently pregnant
  • You live with the person who assaulted you and plan to continue living with them
  • You are being admitted and staying in the hospital (as an inpatient)
  • You do not have a mailing address
  • You have already taken part in this study before
  • You did not have a sexual assault nurse examination (a specific medical examination carried out after a sexual assault) (confirm with trial site)
  • You are currently having thoughts with a plan and intent to harm yourself or someone else
  • You do not read or understand written and spoken English

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 7028950606

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
University of Nevada, Las Vegas
Registry
ClinicalTrials.gov
Start date
14 March 2024
Est. completion
28 February 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Anxiety Sensitivity Index-3 (ASI-3)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov